That said, Recursion doesn't have a single therapy on the market yet. Over the past four years, the company has made little ...

AI is changing how people search – again. Learn what decades of search history can teach us about adapting to the next big ...

What if protest in Central Java small town could be a warning for Jakarta elite? With a population of a little over 1 million people, the impoverished regency is mostly known for its stories of ...

This latest version of Java, due to arrive as a production release on September 16, has 18 features. JDK 25 comes on the heels of JDK 24, a six-month-support release that arrived March 18.

Is Recursion Pharma a buy because of Nvidia’s endorsement? Indeed, Nvidia’s bet on Recursion is notable, but despite the stake and collaboration, the name isn’t without its fair share of risks.

Rallybio (NASDAQ:RLYB) stock soars 114% after agreeing to sell its stake in a rare bone disorder asset, extending cash runway to mid-2027. Read more here.

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part ...

As of Tuesday, June 24, Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 6.02%, which has investors questioning if this is right time to sell.

After layoffs at Recursion, the company’s CEO writes about taking inspiration from an unexpected source: “The Art of Racing in the Rain.” ...

What do you desire? Every day people have an abundance of wants, wishes, and cravings, concerning food, drink, sex, sleep, success, power, wealth, freedom, happiness, love, relationships, security ...